IBDEI0US ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15184,0)
 ;;=386.30^^89^903^41
 ;;^UTILITY(U,$J,358.3,15184,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15184,1,4,0)
 ;;=4^386.30
 ;;^UTILITY(U,$J,358.3,15184,1,5,0)
 ;;=5^Labyrinthitis NOS
 ;;^UTILITY(U,$J,358.3,15184,2)
 ;;=^67891
 ;;^UTILITY(U,$J,358.3,15185,0)
 ;;=088.81^^89^903^42
 ;;^UTILITY(U,$J,358.3,15185,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15185,1,4,0)
 ;;=4^088.81
 ;;^UTILITY(U,$J,358.3,15185,1,5,0)
 ;;=5^Lyme Disease
 ;;^UTILITY(U,$J,358.3,15185,2)
 ;;=^72315
 ;;^UTILITY(U,$J,358.3,15186,0)
 ;;=785.6^^89^903^43
 ;;^UTILITY(U,$J,358.3,15186,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15186,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,15186,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,15186,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,15187,0)
 ;;=031.0^^89^903^44
 ;;^UTILITY(U,$J,358.3,15187,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15187,1,4,0)
 ;;=4^031.0
 ;;^UTILITY(U,$J,358.3,15187,1,5,0)
 ;;=5^Mycobacteria,Atyp,Pulmonary
 ;;^UTILITY(U,$J,358.3,15187,2)
 ;;=^101018
 ;;^UTILITY(U,$J,358.3,15188,0)
 ;;=730.00^^89^903^46
 ;;^UTILITY(U,$J,358.3,15188,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15188,1,4,0)
 ;;=4^730.00
 ;;^UTILITY(U,$J,358.3,15188,1,5,0)
 ;;=5^Osteomyelitis,Acute Unsp
 ;;^UTILITY(U,$J,358.3,15188,2)
 ;;=^272612
 ;;^UTILITY(U,$J,358.3,15189,0)
 ;;=730.10^^89^903^47
 ;;^UTILITY(U,$J,358.3,15189,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15189,1,4,0)
 ;;=4^730.10
 ;;^UTILITY(U,$J,358.3,15189,1,5,0)
 ;;=5^Osteomyelitis,Chron Unsp
 ;;^UTILITY(U,$J,358.3,15189,2)
 ;;=^24427
 ;;^UTILITY(U,$J,358.3,15190,0)
 ;;=380.10^^89^903^48
 ;;^UTILITY(U,$J,358.3,15190,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15190,1,4,0)
 ;;=4^380.10
 ;;^UTILITY(U,$J,358.3,15190,1,5,0)
 ;;=5^Otitis Externa 
 ;;^UTILITY(U,$J,358.3,15190,2)
 ;;=380.10^62807
 ;;^UTILITY(U,$J,358.3,15191,0)
 ;;=382.9^^89^903^49
 ;;^UTILITY(U,$J,358.3,15191,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15191,1,4,0)
 ;;=4^382.9
 ;;^UTILITY(U,$J,358.3,15191,1,5,0)
 ;;=5^Otitis Media
 ;;^UTILITY(U,$J,358.3,15191,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,15192,0)
 ;;=614.9^^89^903^50
 ;;^UTILITY(U,$J,358.3,15192,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15192,1,4,0)
 ;;=4^614.9
 ;;^UTILITY(U,$J,358.3,15192,1,5,0)
 ;;=5^Pelvic Inflammatory Disease
 ;;^UTILITY(U,$J,358.3,15192,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,15193,0)
 ;;=486.^^89^903^52
 ;;^UTILITY(U,$J,358.3,15193,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15193,1,4,0)
 ;;=4^486.
 ;;^UTILITY(U,$J,358.3,15193,1,5,0)
 ;;=5^Pneumonia
 ;;^UTILITY(U,$J,358.3,15193,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,15194,0)
 ;;=136.3^^89^903^51
 ;;^UTILITY(U,$J,358.3,15194,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15194,1,4,0)
 ;;=4^136.3
 ;;^UTILITY(U,$J,358.3,15194,1,5,0)
 ;;=5^Pneumocystosis
 ;;^UTILITY(U,$J,358.3,15194,2)
 ;;=^95635
 ;;^UTILITY(U,$J,358.3,15195,0)
 ;;=601.9^^89^903^56
 ;;^UTILITY(U,$J,358.3,15195,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15195,1,4,0)
 ;;=4^601.9
 ;;^UTILITY(U,$J,358.3,15195,1,5,0)
 ;;=5^Prostatitis NOS
 ;;^UTILITY(U,$J,358.3,15195,2)
 ;;=^99489
 ;;^UTILITY(U,$J,358.3,15196,0)
 ;;=590.80^^89^903^57
 ;;^UTILITY(U,$J,358.3,15196,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15196,1,4,0)
 ;;=4^590.80
 ;;^UTILITY(U,$J,358.3,15196,1,5,0)
 ;;=5^Pyelonephritis NOS
 ;;^UTILITY(U,$J,358.3,15196,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,15197,0)
 ;;=711.00^^89^903^58
 ;;^UTILITY(U,$J,358.3,15197,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15197,1,4,0)
 ;;=4^711.00
 ;;^UTILITY(U,$J,358.3,15197,1,5,0)
 ;;=5^Septic Joint
 ;;^UTILITY(U,$J,358.3,15197,2)
 ;;=^263780
